Bioanalysis of (E)-5-(2-bromovinyl)-2'-deoxyuridine. 1988

H J Reeuwijk, and H Lingeman, and U R Tjaden, and E A de Bruijn, and H J Keizer, and J van der Greef
Center for Bio-Pharmaceutical Sciences, Leiden University, The Netherlands.

(E)-5-(2-Bromovinyl)-2'-deoxyuridine is an antiviral drug that is experimentally used for modulation of the antitumour effect of fluoropyrimidines, such as ftorafur and 5-fluorouracil. The isolation of the analyte, in the presence of 5-fluorouracil, from the matrix is performed either by means of a simple protein precipitation (plasma) or by means of a liquid-liquid extraction with ethyl acetate (urine). Following pretreatment, the analyte is analysed by reversed-phase chromatography and quantified by absorbance detection at 307 nm. The minimum detectable concentration in plasma and urine samples is ca. 6 ng/ml. The recovery after deproteination of plasma samples is 75%, while after liquid-liquid extraction of urine the recovery amounts 92%. The degree of protein binding of the analyte, measured by ultrafiltration, is found to be 97%. These data allow the bioanalysis of (E)-5-(2-bromovinyl)-2'-deoxyuridine for pharmacokinetic studies.

UI MeSH Term Description Entries
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D001973 Bromodeoxyuridine A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors. BUdR,BrdU,Bromouracil Deoxyriboside,Broxuridine,5-Bromo-2'-deoxyuridine,5-Bromodeoxyuridine,NSC-38297,5 Bromo 2' deoxyuridine,5 Bromodeoxyuridine,Deoxyriboside, Bromouracil
D002853 Chromatography, Liquid Chromatographic techniques in which the mobile phase is a liquid. Liquid Chromatography
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral

Related Publications

H J Reeuwijk, and H Lingeman, and U R Tjaden, and E A de Bruijn, and H J Keizer, and J van der Greef
January 2005, Medicinal research reviews,
H J Reeuwijk, and H Lingeman, and U R Tjaden, and E A de Bruijn, and H J Keizer, and J van der Greef
May 1992, Fundamental and applied toxicology : official journal of the Society of Toxicology,
H J Reeuwijk, and H Lingeman, and U R Tjaden, and E A de Bruijn, and H J Keizer, and J van der Greef
August 1984, The Journal of antimicrobial chemotherapy,
H J Reeuwijk, and H Lingeman, and U R Tjaden, and E A de Bruijn, and H J Keizer, and J van der Greef
January 1987, Nucleic acids symposium series,
H J Reeuwijk, and H Lingeman, and U R Tjaden, and E A de Bruijn, and H J Keizer, and J van der Greef
August 1979, Antimicrobial agents and chemotherapy,
H J Reeuwijk, and H Lingeman, and U R Tjaden, and E A de Bruijn, and H J Keizer, and J van der Greef
November 1983, Nucleic acids research,
H J Reeuwijk, and H Lingeman, and U R Tjaden, and E A de Bruijn, and H J Keizer, and J van der Greef
November 1980, British medical journal,
H J Reeuwijk, and H Lingeman, and U R Tjaden, and E A de Bruijn, and H J Keizer, and J van der Greef
January 1983, Nucleic acids symposium series,
H J Reeuwijk, and H Lingeman, and U R Tjaden, and E A de Bruijn, and H J Keizer, and J van der Greef
December 1981, Nucleic acids research,
H J Reeuwijk, and H Lingeman, and U R Tjaden, and E A de Bruijn, and H J Keizer, and J van der Greef
January 1982, Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,
Copied contents to your clipboard!